芪藶強(qiáng)心膠囊治療慢性心功能不全的臨床效果觀察(3)
[3] Shao MJ，Wang SR，Zhao MJ，et al.The effects of velvet antler of deer on cardiac functions of rats with heart failure following myocardial infarction[J].Evid Based Complement Alternat Med，2012，2012：825056.
[4] 中華醫(yī)學(xué)會心血管病學(xué)分會，中華心血管病雜志編輯委員會.中國心力衰竭診斷和治療指南2014[J].中華心血管病雜志，2014，42(2)：98-122.
[5] McMurray JJ，Adamopoulos S，Anker SD，et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012：The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail，2012，14(8)：803-869.
[6] Bettencourt P，Azevedo A，Pimenta J，et al.N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients[J].Circulation，2004，110(15)：2168-2174.
[7] Zou Y，Lin L，Ye Y，et al.Qiliqiangxin inhibits the development of cardiac hypertrophy，remodeling，and dysfunction during 4 weeks of pressure overload in mice[J].J Cardiovasc Pharmacol，2012，59(3)：268-280.
[8] Xiao H，Song Y，Li Y，et al.Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction[J].Cell Immunol，2009，260(1)：51-55.
[9] 李佳彧，楊萍.芪藶強(qiáng)心膠囊對心梗后心力衰竭大鼠periostin蛋白表達(dá)干預(yù)作用的研究[J].中國實(shí)驗(yàn)診斷學(xué)，2009，13(2)：170-172.
[10] 柴松波，王碩仁，姚立芳，等.參松養(yǎng)心膠囊對大鼠心梗后心肌重構(gòu)和室顫閾值影響的研究[J].中國中藥雜志，2009，34(16)：2101-2104.
[11] 林銳波.芪藶強(qiáng)心膠囊對心梗后心衰大鼠心功能及凋亡蛋白caspase-3表達(dá)的影響[D].汕頭：汕頭大學(xué)，2010.
[12] 柴松波，王碩仁，姚立芳，等.參松養(yǎng)心膠囊對大鼠心梗后心室重構(gòu)及其離體心臟動作電位影響的研究[J].北京中醫(yī)藥，2009，28(12)：967-971.
[13] Hunt PJ，Richards AM，Nicholls MG，et al.Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP)：a new marker of cardiac impairment[J].Clin Endocrinol (Oxf)，1997，47(3)：287-296.
[14] Hobbs FD，Davis RC，Roalfe AK，et al.Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure：cohort study in representative and high risk community populations[J].BMJ，2002，324(7352)：1498.
[15] Hartmann F，Packer M，Coats AJS，et al.Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial[J].Circulation，2004，110(13)：1780-1786.
(收稿日期：2014-11-10 本文編輯：郭靜娟) (翟娜等)
[4] 中華醫(yī)學(xué)會心血管病學(xué)分會，中華心血管病雜志編輯委員會.中國心力衰竭診斷和治療指南2014[J].中華心血管病雜志，2014，42(2)：98-122.
[5] McMurray JJ，Adamopoulos S，Anker SD，et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012：The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail，2012，14(8)：803-869.
[6] Bettencourt P，Azevedo A，Pimenta J，et al.N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients[J].Circulation，2004，110(15)：2168-2174.
[7] Zou Y，Lin L，Ye Y，et al.Qiliqiangxin inhibits the development of cardiac hypertrophy，remodeling，and dysfunction during 4 weeks of pressure overload in mice[J].J Cardiovasc Pharmacol，2012，59(3)：268-280.
[8] Xiao H，Song Y，Li Y，et al.Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction[J].Cell Immunol，2009，260(1)：51-55.
[9] 李佳彧，楊萍.芪藶強(qiáng)心膠囊對心梗后心力衰竭大鼠periostin蛋白表達(dá)干預(yù)作用的研究[J].中國實(shí)驗(yàn)診斷學(xué)，2009，13(2)：170-172.
[10] 柴松波，王碩仁，姚立芳，等.參松養(yǎng)心膠囊對大鼠心梗后心肌重構(gòu)和室顫閾值影響的研究[J].中國中藥雜志，2009，34(16)：2101-2104.
[11] 林銳波.芪藶強(qiáng)心膠囊對心梗后心衰大鼠心功能及凋亡蛋白caspase-3表達(dá)的影響[D].汕頭：汕頭大學(xué)，2010.
[12] 柴松波，王碩仁，姚立芳，等.參松養(yǎng)心膠囊對大鼠心梗后心室重構(gòu)及其離體心臟動作電位影響的研究[J].北京中醫(yī)藥，2009，28(12)：967-971.
[13] Hunt PJ，Richards AM，Nicholls MG，et al.Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP)：a new marker of cardiac impairment[J].Clin Endocrinol (Oxf)，1997，47(3)：287-296.
[14] Hobbs FD，Davis RC，Roalfe AK，et al.Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure：cohort study in representative and high risk community populations[J].BMJ，2002，324(7352)：1498.
[15] Hartmann F，Packer M，Coats AJS，et al.Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial[J].Circulation，2004，110(13)：1780-1786.
(收稿日期：2014-11-10 本文編輯：郭靜娟) (翟娜等)